ArticleJournal of inflammation research2026
Saikosaponin A Alleviates Hepatocellular Carcinoma Growth Induced by Chronic Stress via Regulating Tumor Immune Microenvironment.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The tumor immune microenvironment is one of the main factors contributing to tumor metastasis, recurrence and drug resistance. Chronic stress is an important factor mediating the occurrence and progression of tumors by regulating tumor immune microenvironment. Saikosaponins have anti-stress and immunomodulatory effects. However, the therapeutic effects and mechanisms of Saikosaponins in chronic stress-induced tumor progression remain unclear. Aim: This study aimed to investigate the therapeutic effects of Saikosaponins on stress-induced tumor growth and further elucidate the underlying mechanisms. Methods: A mouse model was established using chronic restraint stress. The open field test was used to assess mouse behaviors. Stress hormone levels were measured by ELISA. The levels of cytokines and chemokines were measured by using Luminex. The proportions of T lymphocytes, monocytic-like myeloid-derived suppressor cells (mMDSC), granulocyte-like MDSC (gMDSC), and macrophages were measured by flow cytometry. A CCK8 assay was used to assess tumor cell proliferation. The expressions of adrenergic receptor and Ki67 were measured by immunohistochemistry. Propranolol and isoprenaline were used to investigate the underlying mechanisms. Results: First, we found that Saikosaponin A (SSA) reversed stress-induced depressive behavior. Second, SSA significantly inhibited hepatocellular carcinoma growth and reversed the stress-induced upregulation of Ki67 in tumor tissues. Furthermore, SSA reversed the changes of CD3 Conclusion: Our results suggested that SSA inhibits hepatocellular carcinoma growth by blocking β-adrenergic signaling, thereby enhancing the anti-tumor immune response. Our study provides new insights into the importance of the psychological neuroendocrine immune intervention in the treatment of hepatocellular carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.